CVA Family Office’s Concentrix CNXC Stock Holding History

CVA Family Office’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$55	–	1822
2026 Q1	$55	Buy	+2	New	+$71	﹤0.01%	1829
2025 Q4	–	Sell	-11	Closed	-$508	–	1302
2025 Q3	$508	Hold	11	–	–	﹤0.01%	1244
2025 Q2	$581	Hold	11	–	–	﹤0.01%	1190
2025 Q1	$612	Hold	11	–	–	﹤0.01%	1188
2024 Q4	$476	Buy	+11	New	+$489	﹤0.01%	1248

Other funds holding CNXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

KGI

Kopernik Global Investors Tampa, Florida $1.63B AUM 27.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

CVA Family Office's CNXC Position: Q2 2026 in Review

CVA Family Office sold out of Concentrix (CNXC) in Q2 2026, closing a stake of 2 shares — an estimated $55 sold.

CVA Family Office first reported a position in CNXC in Q4 2024 and held it in 5 quarters. The position peaked at $612 in Q1 2025. 273 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

CVA Family Office reported no remaining Concentrix position as of Q2 2026 after selling out during the quarter.
CVA Family Office sold 2 Concentrix shares in Q2 2026, an estimated $55.
CVA Family Office first reported a position in Concentrix in Q4 2024 and held it in 5 quarters.
CVA Family Office's Concentrix position peaked at $612 in Q1 2025.
273 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.